Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma.

Neoplasma - 1 Sept 2022

Gong Wen-Chen, Han Zhi-Qiang, Guo Ming-Xi, Zhao Shuai, Guo Yu-Hong, Meng Bin, Sun Yan, Chen Lu

Abstract excerpt

The objective of this study was to investigate the expression of SVEP1 in hepatocellular carcinoma (HCC) and to evaluate the association among SVEP1, cancer stem cell-like phenotype, and the prognosis of patients to provide new possibilities for the accurate diagnosis and stratification of HCC. Two hundred HCC and paired adjacent tissues were analyzed by immunohistochemistry and scored, and their relationships...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Adhesion Molecules

Share to Liver Neoplasms

Share to Neoplastic Stem Cells

Share to Phenotype

Share to Prognosis

Source

Identifiers

PMID: 35900319
DOI: 10.4149/neo_2022_220614N629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma.PMID 35900319Read ↗

A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM-/CD133- nonStem Cells into EpCAM+/CD133+ Liver Cancer Stem Cells in HCC Cell Line HuH7.Semantic proximity Read ↗

The Biology of Cancer Stem Cells and Its Clinical Implication in Hepatocellular CarcinomaSemantic proximity Read ↗

Turning Hepatic Cancer Stem Cells Inside Out – A Deeper Understanding through Multiple PerspectivesSemantic proximity Read ↗

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic StrategiesSemantic proximity Read ↗

Correlation of Hepatocellular Carcinoma Stemness Indices and Clinical Characteristics and PrognosisSemantic proximity Read ↗

EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular CarcinomaSemantic proximity Read ↗

ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.Semantic proximity Read ↗

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinomaSemantic proximity Read ↗

C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signallingSemantic proximity Read ↗

PCGF2 and PCGF4 Oppositely Drive Stem-like Properties in Hepatocellular CarcinomaSemantic proximity Read ↗

Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC CellsSemantic proximity Read ↗

The miR‐200b–ZEB1 circuit regulates diverse stemness of human hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.